BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18655533)

  • 1. Treatment of precocious puberty in a female with Prader-Willi syndrome.
    Pusz ER; Rotenstein D
    J Pediatr Endocrinol Metab; 2008 May; 21(5):495-500. PubMed ID: 18655533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central precocious puberty in a girl with Prader-Willi syndrome.
    Lee HS; Hwang JS
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1201-4. PubMed ID: 23740678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central precocious puberty and growth hormone deficiency in a boy with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Schiaffini R; Fierabracci A; Spera S; Maggioni A; Gattinara GC
    Eur J Pediatr; 2008 Dec; 167(12):1455-8. PubMed ID: 18301920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy.
    Ludwig NG; Radaeli RF; Silva MM; Romero CM; Carrilho AJ; Bessa D; Macedo DB; Oliveira ML; Latronico AC; Mazzuco TL
    Arch Endocrinol Metab; 2016; 60(6):596-600. PubMed ID: 27982202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic central precocious puberty with Prader-Willi syndrome: pubertal development with discontinuation of gonadotropin-releasing hormone analog.
    Kobayashi M; Yagasaki H; Tamaru K; Mitsui Y; Inukai T
    Endocrinol Diabetes Metab Case Rep; 2022 Aug; 2022():. PubMed ID: 36017812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central precocious puberty in Prader-Willi syndrome: a narrative review.
    Nicoară DM; Scutca AC; Mang N; Juganaru I; Munteanu AI; Vitan L; Mărginean O
    Front Endocrinol (Lausanne); 2023; 14():1150323. PubMed ID: 37251677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of precocious puberty in two patients with Turner mosaicism.
    Evanchec KA; Rotenstein D
    J Pediatr Endocrinol Metab; 2005 Aug; 18(8):819-22. PubMed ID: 16200850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CENTRAL PRECOCIOUS PUBERTY IN TWO BOYS WITH PRADER-WILLI SYNDROME ON GROWTH HORMONE TREATMENT.
    Monai E; Johansen A; Clasen-Linde E; Rajpert-De Meyts E; Skakkebæk NE; Main KM; Jørgensen A; Jensen RB
    AACE Clin Case Rep; 2019; 5(6):e352-e356. PubMed ID: 31967069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prader-Labhart-Willi syndrome with precocious puberty. (author's transl)].
    Walterspiel JN; Wolff J; Heinze E
    Klin Padiatr; 1981 Mar; 193(2):120-1. PubMed ID: 7194936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade.
    Hirsch HJ; Eldar-Geva T; Bennaroch F; Pollak Y; Gross-Tsur V
    Hum Reprod; 2015 Nov; 30(11):2587-96. PubMed ID: 26345685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precocious puberty in a male with Prader-Labhart-Willi syndrome.
    Vanelli M; Bernasconi S; Caronna N; Virdis R; Terzi C; Giovannelli G
    Helv Paediatr Acta; 1984 Oct; 39(4):373-7. PubMed ID: 6443309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pubertal development in the Prader-Labhart-Willi syndrome.
    Kauli R; Prager-Lewin R; Laron Z
    Acta Paediatr Scand; 1978 Nov; 67(6):763-7. PubMed ID: 362802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypogonadism and pubertal development in Prader-Willi syndrome.
    Crinò A; Schiaffini R; Ciampalini P; Spera S; Beccaria L; Benzi F; Bosio L; Corrias A; Gargantini L; Salvatoni A; Tonini G; Trifirò G; Livieri C;
    Eur J Pediatr; 2003 May; 162(5):327-33. PubMed ID: 12692714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous Deletions in MKRN3 Cause Central Precocious Puberty Without Prader-Willi Syndrome.
    Meader BN; Albano A; Sekizkardes H; Delaney A
    J Clin Endocrinol Metab; 2020 Aug; 105(8):2732-9. PubMed ID: 32480405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD; Kappy MS; Stuart TE; Perelman AH; Hoekstra FT
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature adrenarche in Prader-Willi syndrome is associated with accelerated pre-pubertal growth and advanced bone age.
    Gaston LS; Stafford DE
    J Pediatr Endocrinol Metab; 2023 Feb; 36(2):185-194. PubMed ID: 36458449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM; Harris DA; Egli CA; Conte FA; Kaplan SL; Rivier J; Vale W; Grumbach MM
    J Clin Endocrinol Metab; 1985 Jul; 61(1):142-51. PubMed ID: 3923027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
    Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
    Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.